Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Hand-Foot Syndrome 1

Interventions

Pyridoxine 3 Celecoxib 2 Capecitabine 2 tegafur-gimeracil-oteracil 1 mecobalamin 1 liposomal doxorubicin 1 Vitamin B 6 1 Urea 1 Tobacco Use Cessation Devices 1 Standard of Care 1 S 1 (combination) 1 Radiotherapy 1 Low-Level Light Therapy 1 Diclofenac 1 Brimonidine Tartrate 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hand-Foot Syndrome × Brimonidine Tartrate × Clear all

NCT03173365 2019-01-09

BRIMOCAN

Heinrich-Heine University, Duesseldorf

Phase 2 Terminated

Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡